Original Article
Assessment of the Efficacy and Safety of a Combination of 2 Topical Retinoids (RetinSphere) in Maintaining Post-Treatment Response of Acne to Oral Isotretinoin
Eficacia y seguridad del uso combinado de 2 retinoides tópicos (Retinsphere®) para el mantenimiento de la respuesta obtenida tras el tratamiento con isotretinoína oral
Leído
9346
Vecesse ha leído el artículo
2735
Total PDF
6611
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 85 | 56 | 141 |
| 2025 5 | 390 | 48 | 438 |
| 2025 4 | 395 | 34 | 429 |
| 2025 3 | 183 | 25 | 208 |
| 2025 2 | 169 | 36 | 205 |
| 2025 1 | 112 | 34 | 146 |
| 2024 12 | 122 | 32 | 154 |
| 2024 11 | 120 | 51 | 171 |
| 2024 10 | 84 | 41 | 125 |
| 2024 9 | 120 | 23 | 143 |
| 2024 8 | 134 | 55 | 189 |
| 2024 7 | 80 | 36 | 116 |
| 2024 6 | 99 | 33 | 132 |
| 2024 5 | 103 | 46 | 149 |
| 2024 4 | 133 | 26 | 159 |
| 2024 3 | 95 | 38 | 133 |
| 2024 2 | 81 | 38 | 119 |
| 2024 1 | 76 | 31 | 107 |
| 2023 12 | 87 | 23 | 110 |
| 2023 11 | 111 | 45 | 156 |
| 2023 10 | 99 | 45 | 144 |
| 2023 9 | 58 | 32 | 90 |
| 2023 8 | 76 | 18 | 94 |
| 2023 7 | 123 | 42 | 165 |
| 2023 6 | 86 | 31 | 117 |
| 2023 5 | 122 | 35 | 157 |
| 2023 4 | 57 | 37 | 94 |
| 2023 3 | 94 | 25 | 119 |
| 2023 2 | 109 | 33 | 142 |
| 2022 1 | 44 | 27 | 71 |
| 2022 12 | 72 | 56 | 128 |
| 2022 11 | 97 | 45 | 142 |
| 2022 10 | 84 | 30 | 114 |
| 2022 9 | 53 | 35 | 88 |
| 2022 8 | 76 | 49 | 125 |
| 2022 7 | 67 | 53 | 120 |
| 2022 6 | 78 | 30 | 108 |
| 2022 5 | 53 | 45 | 98 |
| 2022 4 | 84 | 37 | 121 |
| 2022 3 | 81 | 70 | 151 |
| 2022 2 | 79 | 38 | 117 |
| 2021 1 | 79 | 43 | 122 |
| 2021 12 | 66 | 61 | 127 |
| 2021 11 | 67 | 51 | 118 |
| 2021 10 | 64 | 51 | 115 |
| 2021 9 | 46 | 54 | 100 |
| 2021 8 | 50 | 35 | 85 |
| 2021 7 | 44 | 36 | 80 |
| 2021 6 | 46 | 45 | 91 |
| 2021 5 | 54 | 32 | 86 |
| 2021 4 | 120 | 73 | 193 |
| 2021 3 | 87 | 29 | 116 |
| 2021 2 | 120 | 38 | 158 |
| 2020 1 | 64 | 18 | 82 |
| 2020 12 | 69 | 18 | 87 |
| 2020 11 | 40 | 24 | 64 |
| 2020 10 | 40 | 23 | 63 |
| 2020 9 | 101 | 18 | 119 |
| 2020 8 | 81 | 20 | 101 |
| 2020 7 | 87 | 20 | 107 |
| 2020 6 | 24 | 26 | 50 |
| 2020 5 | 32 | 11 | 43 |
| 2020 4 | 37 | 26 | 63 |
| 2020 3 | 24 | 27 | 51 |
| 2020 2 | 4 | 2 | 6 |
| 2020 1 | 8 | 0 | 8 |
| 2019 12 | 8 | 6 | 14 |
| 2019 11 | 4 | 1 | 5 |
| 2019 9 | 0 | 2 | 2 |
| 2019 8 | 4 | 1 | 5 |
| 2019 7 | 8 | 1 | 9 |
| 2019 6 | 4 | 1 | 5 |
| 2019 5 | 6 | 4 | 10 |
| 2019 4 | 2 | 7 | 9 |
| 2019 3 | 3 | 4 | 7 |
| 2019 2 | 2 | 1 | 3 |
| 2019 1 | 3 | 0 | 3 |
| 2018 12 | 3 | 3 | 6 |
| 2018 11 | 4 | 0 | 4 |
| 2018 10 | 1 | 1 | 2 |
| 2018 9 | 4 | 1 | 5 |
| 2018 8 | 0 | 1 | 1 |
| 2018 6 | 0 | 1 | 1 |
| 2018 5 | 0 | 1 | 1 |
| 2018 4 | 1 | 8 | 9 |
| 2018 2 | 42 | 9 | 51 |
| 2018 1 | 42 | 7 | 49 |
| 2017 12 | 29 | 10 | 39 |
| 2017 11 | 22 | 10 | 32 |
| 2017 10 | 37 | 11 | 48 |
| 2017 9 | 18 | 13 | 31 |
| 2017 8 | 29 | 16 | 45 |
| 2017 7 | 30 | 10 | 40 |
| 2017 6 | 33 | 25 | 58 |
| 2017 5 | 24 | 22 | 46 |
| 2017 4 | 20 | 22 | 42 |
| 2017 3 | 29 | 38 | 67 |
| 2017 2 | 11 | 10 | 21 |
| 2016 1 | 6 | 5 | 11 |
| 2016 12 | 16 | 15 | 31 |
| 2016 11 | 13 | 13 | 26 |
| 2016 10 | 14 | 30 | 44 |
| 2016 9 | 0 | 10 | 10 |
| 2016 8 | 0 | 9 | 9 |
| 2016 7 | 8 | 2 | 10 |
| 2016 6 | 20 | 1 | 21 |
| 2016 5 | 23 | 5 | 28 |
| 2016 4 | 9 | 3 | 12 |
| 2016 3 | 12 | 3 | 15 |
| 2016 2 | 10 | 4 | 14 |
| 2015 1 | 19 | 1 | 20 |
| 2015 12 | 6 | 2 | 8 |
| 2015 11 | 8 | 2 | 10 |
| 2015 10 | 14 | 10 | 24 |
| 2015 9 | 9 | 3 | 12 |
| 2015 8 | 0 | 4 | 4 |
| 2015 7 | 13 | 0 | 13 |
| 2015 6 | 14 | 0 | 14 |
| 2015 5 | 12 | 5 | 17 |
| 2015 4 | 12 | 10 | 22 |
| 2015 3 | 25 | 6 | 31 |
Mostrar todo
